BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23328704)

  • 1. The WNT signaling pathway from ligand secretion to gene transcription: molecular mechanisms and pharmacological targets.
    Baarsma HA; Königshoff M; Gosens R
    Pharmacol Ther; 2013 Apr; 138(1):66-83. PubMed ID: 23328704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNT secretion and signalling in human disease.
    Herr P; Hausmann G; Basler K
    Trends Mol Med; 2012 Aug; 18(8):483-93. PubMed ID: 22796206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of RAS/β-catenin interactions.
    Zeller E; Hammer K; Kirschnick M; Braeuning A
    Arch Toxicol; 2013 Apr; 87(4):611-32. PubMed ID: 23483189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
    Schepsky A; Bruser K; Gunnarsson GJ; Goodall J; Hallsson JH; Goding CR; Steingrimsson E; Hecht A
    Mol Cell Biol; 2006 Dec; 26(23):8914-27. PubMed ID: 17000761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signaling signaling at and above the receptor level.
    Buechling T; Boutros M
    Curr Top Dev Biol; 2011; 97():21-53. PubMed ID: 22074601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge.
    Anastasilakis AD; Polyzos SA; Toulis KA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):383-8. PubMed ID: 21897222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylenimine-cationized beta-catenin protein transduction activates the Wnt canonical signaling pathway more effectively than cationic lipid-based transduction.
    Kitazoe M; Futami J; Nishikawa M; Yamada H; Maeda Y
    Biotechnol J; 2010 Apr; 5(4):385-92. PubMed ID: 20235145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Canonical Wnt signaling pathway and cellular responses].
    Kikuchi A
    Clin Calcium; 2013 Jun; 23(6):799-807. PubMed ID: 23719491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
    Jin T; George Fantus I; Sun J
    Cell Signal; 2008 Oct; 20(10):1697-704. PubMed ID: 18555664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of the Wnt/β-catenin/TCF response elements in the human versican promoter.
    Rahmani M; Carthy JM; McManus BM
    Methods Mol Biol; 2012; 836():35-52. PubMed ID: 22252626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Wnt signaling: can we safely eradicate cancer stem cells?
    Takahashi-Yanaga F; Kahn M
    Clin Cancer Res; 2010 Jun; 16(12):3153-62. PubMed ID: 20530697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New avenues to target Wnt/β-catenin signaling.
    Verkaar F; Zaman GJ
    Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Wnt /β-catenin signaling pathway in the adult neurogenesis.
    Zhang L; Yang X; Yang S; Zhang J
    Eur J Neurosci; 2011 Jan; 33(1):1-8. PubMed ID: 21073552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signalling in adrenal physiology and tumour development.
    Berthon A; Martinez A; Bertherat J; Val P
    Mol Cell Endocrinol; 2012 Mar; 351(1):87-95. PubMed ID: 21930188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin in the race to fracture repair: in it to Wnt.
    Silkstone D; Hong H; Alman BA
    Nat Clin Pract Rheumatol; 2008 Aug; 4(8):413-9. PubMed ID: 18560386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases.
    Boudin E; Fijalkowski I; Piters E; Van Hul W
    Semin Arthritis Rheum; 2013 Oct; 43(2):220-40. PubMed ID: 23433961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.